Stocksigma LogoStocksigma Logo

Jeena Sikho Lifecare Reports Q2FY27 Results and Outlines Bed Expansion Strategy

Jeena Sikho Lifecare reported Q2FY27 revenue growth of 24% YoY to ₹235.13 crore, while EBITDA declined 22% YoY to ₹72.02 crore with margins contracting to

Jeena Sikho Lifecare Reports Q2FY27 Results and Outlines Bed Expansion Strategy

Jeena Sikho Lifecare Ltd · Investor Presentation · 16 Nov 2026, 2:44 am

Jeena Sikho Lifecare Reports Q2FY27 Results and Outlines Bed Expansion Strategy Jeena Sikho Lifecare reported Q2FY27 revenue growth of 24% YoY to ₹235.13 crore, while EBITDA declined 22% YoY to ₹72.02 crore with margins contracting to 31% from 48% in Q2FY26. Profit after tax fell 38% YoY to ₹36.34 crore, impacted by brand-building outlays, manpower additions, and higher ECL provisions. H1FY27 revenue rose 26% YoY to ₹459.53 crore with a 36% EBITDA margin. Operating 2,424 beds across 122 facilities, the debt-free company targets scaling to 5,000 beds within 2–5 years via internal accruals.

Original exchange filing (PDF)

More announcements from Jeena Sikho Lifecare Ltd

All Jeena Sikho Lifecare Ltd announcements